These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6252519)

  • 21. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis.
    Milhaud G; Talbot JN; Coutris G
    Biomedicine; 1975 May; 22(3):223-32. PubMed ID: 809068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX; Li H
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calcium.
    Thamsborg G; Storm TL; Brinch E; Sykulski R; Fogh-Andersen N; Holmegaard SN; Sørensen OH
    Calcif Tissue Int; 1990 Jan; 46(1):5-8. PubMed ID: 2153040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrocalcitonin and the response to parathyroid hormone.
    Anast C; Arnaud CD; Rasmussen H; Tenenhouse A
    J Clin Invest; 1967 Jan; 46(1):57-64. PubMed ID: 6018750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone and calcitonin: no direct effect on vitamin D3-mediated, intestinal calcium absorptive mechanism.
    Corradino RA
    Horm Metab Res; 1976 Nov; 8(6):485-8. PubMed ID: 187537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
    Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
    Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic bone disease--recent developments.
    Epstein S
    S Afr Med J; 1974 Feb; 48(9):350-2. PubMed ID: 4360865
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of parathyroid hormone and calcitonin on stop-flow patterns of cyclic AMP, sodium, potassium, calcium and inorganic phosphate in thyroparathyroidectomized rabbits.
    Tabei K; Asano Y; Imai M
    Miner Electrolyte Metab; 1984; 10(1):36-42. PubMed ID: 6330514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H; Sipahioğlu S; Aksoy N; Baykara İ; Işıkan UE
    Acta Orthop Traumatol Turc; 2015; 49(2):160-5. PubMed ID: 26012937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of parathyroid hormone and calcitonin on urinary excretion of calcium, magnesium and inorganic phosphorus in chronically catheterized foetal lambs in utero.
    Barlet JP; Davicco MJ; Lefaivre J
    J Physiol (Paris); 1982-1983; 78(9):809-13. PubMed ID: 7187765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone secretory responses to peroral phosphate and stimulability of serum levels of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene by calcium in normal subjects and osteoporotic patients.
    Dambacher MA; Ittner J; Muff R; Fischer JA
    Adv Exp Med Biol; 1986; 208():345-9. PubMed ID: 3031943
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR; Aldred JP; Neer RM; Krane SM; Potts JT; Bloch KJ
    J Clin Invest; 1972 Sep; 51(9):2331-8. PubMed ID: 4674133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G; Franchimont P; Gaspar S; Gysen P; Kanis JA
    Ann Endocrinol (Paris); 1981; 42(3):265-75. PubMed ID: 7316460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmon calcitonin.
    Orr PM
    Orthop Nurs; 1993; 12(5):45-7, 70. PubMed ID: 8233579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.